Mirena® intrauterine system in the treatment of menstrual disorders: A survey of UK patients' experience, acceptability and satisfaction

Summary

Our study investigated the personal experience and satisfaction of patients with menstrual disorders treated with the Mirena® intrauterine system in secondary care. A retrospective questionnaire was sent to all 1,100 women treated with a Mirena® intrauterine system in the Menstrual Disorders Clinic between 1995–2003 at the Queens' Medical Centre, Nottingham, England. A total of 1,056 (96%) women responded and were included in the study. The majority (73%) of women continued to use the Mirena®. The women reported a decrease in the heaviness, frequency and pain associated with their period. The commonest side-effect experienced was spotting (19%). Women ranked their satisfaction on a scale of 1–10, with a mean score of 7.07/10. The majority of women are satisfied with the Mirena® as a treatment for menstrual disorders. Less than 5% of the women required subsequent operative treatment for menstrual disorders following treatment with the Mirena®.

Keywords:

• Mirena® intrauterine system
• menstrual disorders
• patient satisfaction
• continuation rate

Notes

The rights in contribution prepared by an employee of the UK government department, agency, or other Crown body belong to the Crown and are not subject to United States copyright laws.